IN2014DN08984A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN08984A IN2014DN08984A IN8984DEN2014A IN2014DN08984A IN 2014DN08984 A IN2014DN08984 A IN 2014DN08984A IN 8984DEN2014 A IN8984DEN2014 A IN 8984DEN2014A IN 2014DN08984 A IN2014DN08984 A IN 2014DN08984A
- Authority
- IN
- India
- Prior art keywords
- pro
- lys
- gly
- thr
- arg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to biochemistry and biotechnology and is directed to producing peptides with sex- and sexual- fimction-stimulating activity of general formula: A-Thr-Lys-Pro-B-C-D-X, where A is 0, Met, Met(0), Thr, Ala, His, Phe, Lys, ARG PRO GL PRO Gly, В is 0, Gly, Asp, Trp, Gin, Asn, Tyr, BOс -он H - Pro, Arg, С is 0, Arg, Phe, Tyr, Gly, His, BOC- Pro, Lys, D is 0, Val, Gly, Tyr, Trp, Phe, His, X is OH, OCH3, NH , where 0 is the ab- B C- 3 H- - Bzl sence of an amino acid residue, under the BO C- OBzl condition that, if A^0, then В and/or С and/or D ), and if B ), then С and/or D ), O H- OBzl excluding the peptides Phe-Thr-Lys-Pro- N0 BOC OBzl Gly, Thr-Lys-Pro-Pro-Arg, Thr-Lys-Pro- < O, VI Arg-Gly. The invention is also directed to a BOC H method for producing the peptides men- H- -OH tioned by genetic engineering methods.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012111965A RU2507212C3 (en) | 2012-03-28 | 2012-03-28 | METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE |
| PCT/RU2013/000433 WO2013151467A2 (en) | 2012-03-28 | 2013-05-28 | Method for producing a recombinant peptide and resultant peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08984A true IN2014DN08984A (en) | 2015-05-22 |
Family
ID=49301137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8984DEN2014 IN2014DN08984A (en) | 2012-03-28 | 2013-05-28 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9409947B2 (en) |
| EP (2) | EP2876113B1 (en) |
| BR (1) | BR112014023888B1 (en) |
| CA (1) | CA2868820C (en) |
| DK (1) | DK2876113T3 (en) |
| ES (1) | ES2768300T3 (en) |
| IL (1) | IL234753B (en) |
| IN (1) | IN2014DN08984A (en) |
| PL (1) | PL2876113T3 (en) |
| PT (1) | PT2876113T (en) |
| RU (1) | RU2507212C3 (en) |
| WO (1) | WO2013151467A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2507212C3 (en) * | 2012-03-28 | 2022-05-04 | Общество С Ограниченной Ответственностью "Айвикс" | METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE |
| RU2655763C2 (en) * | 2016-10-24 | 2018-05-29 | Общество С Ограниченной Ответственностью "Айвикс" | Pharmaceutical composition and method for treating female sexual dysfunctions |
| RU2626002C1 (en) | 2016-10-24 | 2017-07-21 | Общество С Ограниченной Ответственностью "Айвикс" | New group of peptides for treatment of female sexual dysfunction |
| RU2709503C1 (en) * | 2019-05-23 | 2019-12-18 | Акционерное общество "Инновационный научно-производственный центр "Пептоген" (АО "ИНПЦ "Пептоген") | USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
| RU1124544C (en) * | 1983-06-30 | 1995-01-09 | Институт молекулярной генетики РАН | Heptapeptide possessing properties of psychostimulator of prolonged action with immunotropic activity |
| RU2058791C1 (en) | 1989-01-11 | 1996-04-27 | Государственное предприятие "Элер-микро" | Stimulating agent of reproductive capability in warm-blooded animal |
| US5872100A (en) | 1990-05-11 | 1999-02-16 | Deghenghi; Romano | Peptides containing D-2-Alkyl-Tryptophan |
| DE69429768T2 (en) | 1993-04-05 | 2002-09-19 | Competitive Technologies, Inc. | DIAGNOSIS AND TREATMENT OF ERECTILE FUNCTIONAL FAULTS |
| US5932548A (en) | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
| RU2155065C1 (en) | 1999-04-23 | 2000-08-27 | Институт молекулярной генетики РАН | Anxiolytic agent and pharmaceutical composition with anxiolytic effect |
| US6211156B1 (en) | 1999-11-10 | 2001-04-03 | Asta Medica A.G. | Peptides for treatment of erectile dysfunction |
| RU2252779C1 (en) | 2003-09-23 | 2005-05-27 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | Method for preventing and treating ulcers of gastro-intestinal tract |
| RU2290195C1 (en) | 2005-04-21 | 2006-12-27 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | Agent possessing anti-coagulating, anti-thrombocytic, anti-thrombosis, fibrin-depolymerizing and fibrinolytic activity |
| CN101302246B (en) | 2007-05-09 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof |
| WO2009033792A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| US7618801B2 (en) | 2007-10-30 | 2009-11-17 | Danison US Inc. | Streptomyces protease |
| RU2411249C2 (en) * | 2008-12-11 | 2011-02-10 | Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) | Agent for viruses: encephalomyocarditis, influenza type a, herpes simplex type 2 |
| RU2404793C1 (en) | 2009-06-04 | 2010-11-27 | Общество с ограниченной ответственностью Био Пептид | Stimulator of genital, sexual and reproductive function |
| EA200900804A1 (en) * | 2009-06-08 | 2010-08-30 | Общество С Ограниченной Ответственностью "Витанта" | MEANS ACTIVATING SEXUAL FUNCTION |
| RU2507212C3 (en) * | 2012-03-28 | 2022-05-04 | Общество С Ограниченной Ответственностью "Айвикс" | METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE |
-
2012
- 2012-03-28 RU RU2012111965A patent/RU2507212C3/en active IP Right Revival
-
2013
- 2013-05-28 PL PL13772776T patent/PL2876113T3/en unknown
- 2013-05-28 PT PT137727764T patent/PT2876113T/en unknown
- 2013-05-28 DK DK13772776.4T patent/DK2876113T3/en active
- 2013-05-28 US US14/388,080 patent/US9409947B2/en active Active
- 2013-05-28 EP EP13772776.4A patent/EP2876113B1/en active Active
- 2013-05-28 IN IN8984DEN2014 patent/IN2014DN08984A/en unknown
- 2013-05-28 EP EP19206860.9A patent/EP3650457B1/en active Active
- 2013-05-28 CA CA2868820A patent/CA2868820C/en active Active
- 2013-05-28 WO PCT/RU2013/000433 patent/WO2013151467A2/en active Application Filing
- 2013-05-28 BR BR112014023888-0A patent/BR112014023888B1/en active IP Right Grant
- 2013-05-28 ES ES13772776T patent/ES2768300T3/en active Active
-
2014
- 2014-09-21 IL IL234753A patent/IL234753B/en active IP Right Grant
-
2016
- 2016-07-18 US US15/213,039 patent/US20170158735A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013151467A3 (en) | 2014-01-09 |
| BR112014023888B1 (en) | 2021-12-07 |
| ES2768300T3 (en) | 2020-06-22 |
| RU2012111965A (en) | 2013-10-10 |
| EP3650457A1 (en) | 2020-05-13 |
| PL2876113T3 (en) | 2020-06-15 |
| EP3650457B1 (en) | 2021-03-17 |
| CA2868820A1 (en) | 2013-10-10 |
| BR112014023888A2 (en) | 2018-05-29 |
| US20170158735A1 (en) | 2017-06-08 |
| EP2876113A4 (en) | 2017-03-01 |
| RU2507212C2 (en) | 2014-02-20 |
| RU2507212C3 (en) | 2022-05-04 |
| EP2876113A2 (en) | 2015-05-27 |
| US9409947B2 (en) | 2016-08-09 |
| WO2013151467A2 (en) | 2013-10-10 |
| DK2876113T3 (en) | 2020-02-03 |
| PT2876113T (en) | 2020-02-03 |
| IL234753B (en) | 2018-11-29 |
| EP2876113B1 (en) | 2019-11-06 |
| US20150111837A1 (en) | 2015-04-23 |
| CA2868820C (en) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598356A (en) | Antigenic tau peptides and uses thereof | |
| NZ593550A (en) | ANTI-Siglec-15 ANTIBODY | |
| MX2011011960A (en) | Cell membrane-permeable peptides. | |
| MX2011012906A (en) | Recombinant production of peptides. | |
| MY157239A (en) | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use | |
| NZ597692A (en) | Anti-IGF antibodies | |
| MX348464B (en) | Immunity inducer. | |
| NZ602845A (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| NZ596617A (en) | Melanocortin receptor-specific peptides | |
| AR078377A1 (en) | ANTI-VEGF-C ANTIBODIES (ISOLATED ANTI-VASCULAR ENDOTELIAL GROWTH FACTOR C) AND ITS METHODS OF USE | |
| NZ743910A (en) | Purification of iduronate-2-sulfatase | |
| IN2014DN08984A (en) | ||
| NZ609216A (en) | Anticancer fusion protein | |
| WO2010144231A3 (en) | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles | |
| NZ604412A (en) | Vaccine and methods to reduce campylobacter infection | |
| EP2589658A4 (en) | Partial region polypeptide of reic/dkk-3 protein | |
| NZ601142A (en) | Composition for improving brain function and method for improving brain function | |
| RU2015119523A (en) | A NEW METHOD FOR TREATING SPINAL CORD INJURY USING THE HMGB1 FRAGMENT | |
| IN2014DN09367A (en) | ||
| NZ586074A (en) | LCLRP peptides, constructs and uses thereof | |
| MX2016007407A (en) | Protease resistant peptides. | |
| IN2014KN00866A (en) | ||
| MX2010009071A (en) | Isolated peptides having phospholipase inhibitory activity. | |
| SG195302A1 (en) | Shk-based pharmaceutical compositions and methods of manufacturing and using the same | |
| IN2012DN05886A (en) |